Skip to main content

Octaplas FDA Approval History

Last updated by Judith Stewart, BPharm on May 19, 2020.

FDA Approved: Yes (First approved January 17, 2013)
Brand name: Octaplas
Generic name: pooled plasma (human)
Dosage form: Solution for Intravenous Infusion
Company: Octapharma
Treatment for: Bleeding Disorder

Octaplas is a solvent/detergent (S/D) treated, pooled human plasma indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies and plasma exchange in patients with thrombotic thrombocytopenic purpura.

Development timeline for Octaplas

Jan 17, 2013Approval FDA Approves Octaplas to Treat Patients with Blood Clotting Disorders

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.